Interpreting International Certification Standards For RF Transseptal Puncture Needles
Jul 01, 2026
https://pmc.ncbi.nlm.nih.gov/articles/PMC4333976/
Cardiac interventional devices directly contact core human organs; their quality and safety concern patient lives. From production, processing, and cleaning to finished product delivery, the Manners RF transseptal puncture needle establishes a full-chain, stringent quality control system throughout. Relying on the dual certifications of ISO 9001:2015 Quality Management System and ISO 13485 Medical Device Specialized Quality System, it guarantees the precision quality and clinical safety of every single product.
The ISO 9001:2015 general quality management system standardizes the product's全生命周期 (full lifecycle) production process. Manners has established standardized operating procedures from raw material procurement, equipment calibration, process machining to finished product packaging, realizing traceable and controllable production processes. Before warehousing, raw materials are individually verified for hardness, composition, and biocompatibility to prevent unqualified base materials from entering production. Production equipment is regularly calibrated and maintained to ensure the Citizen Cincom R04 machine tools consistently maintain micrometer-level machining accuracy, avoiding product defects caused by equipment errors.
Focusing on the medical device-specific ISO 13485 certification system, the company strictly adheres to medical device production norms, concentrating on three core QC dimensions: sterility, precision, and safety. In precision dimensional QC, all finished puncture needles undergo individual testing for diameter, length, and angular tolerance. Strict control is maintained over ±0.01 mm dimensional errors and 0.1° angular errors, eliminating surgical adaptation failures caused by dimensional deviations. In the surface QC stage, surface roughness and finish are inspected to ensure no burrs, micro-cracks, or contaminant residues exist, complying with sterile implant standards for interventional devices.
In the post-processing QC stage, the electropolishing process strictly benchmarks against the ASTM B912 industry standard, precisely controlling the surface stripping thickness to unify the roughness standard of the finished needle tip bevel to Ra 0.25 μm. This ensures consistent performance and balanced quality across all products. After ultrasonic cleaning, dual verifications of microscopic detection and contaminant residue detection are conducted to ensure no trace impurities remain, eliminating risks of intraoperative infection and embolism.
The final finished product inspection conducts multi-dimensional performance tests on structural integrity, corrosion resistance, and RF conduction stability. By simulating complex clinical surgical environments, it verifies puncture stability, kink resistance, and energy conduction accuracy. The packaging stage supports both standard PP sterile packaging and customized packaging, utilizing全程 (whole-process) sterile sealing to prevent secondary contamination during storage and transportation. This complete QC process has earned international authoritative recognition for the clinical safety and stability of Manners RF transseptal puncture needles, making them suitable for clinical use in medical institutions worldwide.








